ARE YOU LIVING WITH COPD?

Last updated: February 17, 2024
Sponsor: Astra Zeneca
Overall Status: Active - Recruiting

Phase

3

Condition

Copd (Chronic Obstructive Pulmonary Disease)

Treatment

N/A

Clinical Study ID

TX322065
D5985C00002
  • Ages 40-80
  • All Genders

Study Summary

North Carolina Clinical Research is enrolling for a COPD study with an already approved treatment that uses a new type of inhaler.

Eligibility Criteria

Inclusion

Inclusion Criteria

You may be eligible if you:

  • Are 40 - 80 years of age
  • Have a diagnoses of COPD
  • Are a current or former smoker
  • Can attend 6 morning study visits over approximately 3.5 months
  • Additional criteria may apply

Contact Site for Exclusion Criteria Conveniently located near UNC-Rex Hospital off of Lake Boone Trail in Raleigh

Study Design

Study Start date:
February 01, 2024
Estimated Completion Date:
February 01, 2025

Study Description

Qualified participants may receive:

  • Investigational study medication and study-related care at no cost (insurance is not required)
  • Compensation up to $1250 for study-related time and travel

Connect with a study center

  • North Carolina Clinical Research

    Raleigh, NC 27607
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.